In a striking development, Cigna Group has halted negotiations with Humana Inc., dashing what many expected to be one of the most significant deals of the decade, according to a report by Crystal Tse and Michelle F. Davis from Bloomberg Industry Group. The full report reveals that the negotiations foundered on matters of pricing.
Cigna, unable to arrive at an agreement with Humana over the price, chose to step away from the discussions, even more so as their shares experienced a downswing. Despite both parties identifies strategic sense in the merger and the confidence that regulatory roadblocks could be navigated, people familiar with the matter reveal the pricing challenge proved insurmountable. These insiders chose to remain anonymous due to the confidential nature of the information.
This turn of events marks a departure from what industry observers predicted. Many anticipated the union of these insurance firms would usher in a powerful entity capable of making substantial waves in the health sector.
In the wake of this development, Cigna appears to be exploring an alternative strategy. As per the Bloomberg report, the company now intends to pursue stock buybacks. Precise details regarding this plan, however, remain undisclosed at this point in time.